Delivery Order SPE2DB22D3004-SPE2DB25FSB60
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) with a ceiling value of $33,370.13. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $3,977.47. This contract represents a firm fixed-price delivery order under a competitive, non-set-aside procurement and is scheduled for completion by July 25, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office and serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $28,364.36. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to be completed by July 22, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) valued at $10,076.28. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $30,440.85. This firm fixed-price delivery order, which is a child contract under a larger vehicle, reflects no set-aside designation and represents a competitively awarded transaction. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a $8,062.00 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This is a firm fixed-price delivery order with no set-aside designation, utilizing open competition. The contract is set to complete on August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Myrbetriq ER 25 mg tablets (30-count units) with a ceiling value of $1,346.80. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by July 22, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Myrbetriq ER 50 mg tablets in a 90-count configuration, with a ceiling value of $6,187.69. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count) with a ceiling value of $3,978.84. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a completion date of August 1, 2025. This delivery order operates...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) with a contract ceiling value of $7,553.60. This is a firm fixed-price delivery order with no set-aside designation, utilizing open and competitive procurement procedures. The contract is set to complete by August 1, 2025, and represents a direct fulfillment of pharmaceutical supply needs through AmerisourceBergen's existing...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSB60Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) valued at $6,100.96. This competitively awarded, firm fixed-price delivery order is not set-aside and is scheduled for completion by August 20, 2025. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government, with fulfillment occurring at the contractor's Conshohocken, Pennsylvania location. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare systems globally, including serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. Myrbetriq, a brand-name medication used in urological treatment, exemplifies the specialized pharmaceutical commodities delivered through this strategic sourcing vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 8/19/25 |